<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Mepergan Fortis Capsules; Final Decision on Proposal To Refuse Approval of Supplemental New Drug Application; Availability of Final Decision</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Mepergan Fortis Capsules; Final Decision on Proposal To Refuse Approval of Supplemental New Drug Application; Availability of Final Decision</h1>
    <p class="timestamp">Published: 2017-11-16 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or the Agency) is announcing that the Initial Decision of the Administrative Law Judge (ALJ), to refuse approval of the supplemental new drug application (sNDA) for Mepergan Fortis Capsules (MFC) (meperidine HCl, promethazine HCl), is the final decision of the Commissioner by operation of law. In the Initial Decision, the ALJ found that MFC had not been shown to be supported by substantial evidence consisting of adequate and well- controlled studies to be ef...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2017-24806</p>
    <p><strong>Publication Date:</strong> 2017-11-16</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2017/11/16/2017-24806/mepergan-fortis-capsules-final-decision-on-proposal-to-refuse-approval-of-supplemental-new-drug">https://www.federalregister.gov/documents/2017/11/16/2017-24806/mepergan-fortis-capsules-final-decision-on-proposal-to-refuse-approval-of-supplemental-new-drug</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2017-24806</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
